5.38 - 5.60
4.95 - 8.28
2.3K / 2.4K (Avg.)
-279.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
4.01%
Revenue growth at 75-90% of VALMT.HE's 4.81%. Bill Ackman would push for innovation or market expansion to catch up.
103.08%
Gross profit growth above 1.5x VALMT.HE's 2.93%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
98.14%
Positive EBIT growth while VALMT.HE is negative. John Neff might see a substantial edge in operational management.
98.14%
Positive operating income growth while VALMT.HE is negative. John Neff might view this as a competitive edge in operations.
92.82%
Positive net income growth while VALMT.HE is negative. John Neff might see a big relative performance advantage.
92.17%
Positive EPS growth while VALMT.HE is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
92.17%
Positive diluted EPS growth while VALMT.HE is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-8.36%
Share reduction while VALMT.HE is at 0.02%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-8.36%
Reduced diluted shares while VALMT.HE is at 0.02%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
115.38%
Positive OCF growth while VALMT.HE is negative. John Neff would see this as a clear operational advantage vs. the competitor.
205.88%
Positive FCF growth while VALMT.HE is negative. John Neff would see a strong competitive edge in net cash generation.
-4.63%
Negative 10Y revenue/share CAGR while VALMT.HE stands at 29.63%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-4.63%
Negative 5Y CAGR while VALMT.HE stands at 11.24%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-4.63%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
536.09%
10Y OCF/share CAGR above 1.5x VALMT.HE's 278.13%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
536.09%
Positive OCF/share growth while VALMT.HE is negative. John Neff might see a comparative advantage in operational cash viability.
536.09%
3Y OCF/share CAGR above 1.5x VALMT.HE's 192.67%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
85.78%
Net income/share CAGR above 1.5x VALMT.HE's 8.49% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
85.78%
Positive 5Y CAGR while VALMT.HE is negative. John Neff might view this as a strong mid-term relative advantage.
85.78%
Positive short-term CAGR while VALMT.HE is negative. John Neff would see a clear advantage in near-term profit trajectory.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-10.15%
Inventory is declining while VALMT.HE stands at 4.32%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-2.08%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
8.39%
Positive BV/share change while VALMT.HE is negative. John Neff sees a clear edge over a competitor losing equity.
-1.14%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.